BUZZ-Evercore ISI 下调大都会人寿评级,理由是估值过高

路透中文
Jan 07
BUZZ-<a href="https://laohu8.com/S/EVR">Evercore</a> ISI 下调<a href="https://laohu8.com/S/MET">大都会人寿</a>评级,理由是估值过高

1月6日 - ** Evercore ISI将保险公司大都会人寿MET.N的评级从 "跑赢大盘 "下调至 "与大盘持平",理由是该公司的盈利预期出现下滑,与中型股同行相比估值不再便宜。

** 券商称,与同行相比,公共债券再投资利差较低,商业抵押贷款组合风险较高,这限制了该公司的盈利上升空间,而且如果信贷或商业房地产状况恶化,该公司的估值倍数也会受到影响。

** 风险转移交易可能会成为催化剂,但 MET 可能会等待长期护理风险的更好定价,目前该风险可带来正利润率和现金流--券商称

** Evercore 还将目标价从 108 美元下调至 97 美元,这意味着该股较上一交易日收盘价仍有 18.6% 的上涨空间。

** 17位分析师中有13位将该股评为 "强烈买入 "或 "买入",4位评为 "持有";他们的预测中值为94.50美元--数据由LSEG编制

** 包括本交易日的走势在内,MET在过去12个月中下跌了1.13%。

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10